Mitofilin and titin as target antigens in melanoma-associated retinopathy
Article first published online: 27 NOV 2006
Copyright © 2006 Wiley-Liss, Inc.
International Journal of Cancer
Volume 120, Issue 4, pages 788–795, 15 February 2007
How to Cite
Pföhler, C., Preuss, K.-D., Tilgen, W., Stark, A., Regitz, E., Fadle, N. and Pfreundschuh, M. (2007), Mitofilin and titin as target antigens in melanoma-associated retinopathy. Int. J. Cancer, 120: 788–795. doi: 10.1002/ijc.22384
- Issue published online: 27 DEC 2006
- Article first published online: 27 NOV 2006
- Manuscript Accepted: 29 AUG 2006
- Manuscript Received: 24 JUN 2006
- Deutsche Krebshilfe (German Cancer Aid)
- melanoma-associated retinopathy;
Melanoma-associated retinopathy (MAR) is a rare paraneoplastic syndrome in patients with melanoma. Since the onset of MAR symptoms is often associated with tumor progression or recrudescence of metastases, MAR-related symptoms are prognostic relevant. The pathomechanism underlying MAR is supposed to result from antibody production against yet unknown melanoma-associated antigens that are also expressed in retinal tissue, leading to the destruction of retinal cells and resulting in defective signal transduction. Only a 35 kDa protein in Müller glial cells, a 22 kDa neuronal antigen and retinal transducin have been identified as MAR-associated antigens to date. To identify additional antigens potentially involved in the pathogenesis of MAR, we screened a retina cDNA phage library for reactivity with antibodies in the sera from 9 patients with MAR or subclinical MAR using the serological analysis of recombinantly expressed clones (SEREX) approach. Six sera from melanoma patients without evidence of MAR and 10 sera from healthy donors served as controls. Mitofilin and titin were identified as antigens against which antibodies were found exclusively in sera of MAR patients, but not in the sera of MM patients without MAR or healthy donors. This is the first study to demonstrate that titin is highly expressed from retinal tissue and melanoma. The fact that none of the MAR-associated antigens detected to date by their capacity to elicit a humoral immune response is located on the cell surface questions a major pathogenetic role of the respective antibodies and suggests that cellular, rather than humoral mechanisms are operative in the primary immune attack against the retina in MAR. © 2006 Wiley-Liss, Inc.